Get started Log in

HIK — Hikma Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Market Cap
£3.50bn
Enterprise Value
£4.48bn
Revenue
$3.16bn

RCS - Hikma Pharmaceutical - Hikma enters licensing partnership with Perrigo
09/07/2018 09:00Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
02/07/2018 17:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
15/06/2018 15:25Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
08/06/2018 11:55Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
04/06/2018 10:30Announcement
RCS - Hikma Pharmaceutical - Hikma appoints Chief Transformation Officer
04/06/2018 09:00Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
01/06/2018 11:35Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
30/05/2018 15:25Announcement
RCS - Hikma Pharmaceutical - Hikma launches Methylergonovine Maleate Tablets
30/05/2018 09:00Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
23/05/2018 10:25Announcement
REG - Hikma Pharmaceutical - AGM Results
18/05/2018 13:05Announcement
REG - Hikma Pharmaceutical - Trading Statement
18/05/2018 07:05Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
17/05/2018 13:45Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
17/05/2018 13:10Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
15/05/2018 14:30Announcement
RCS - Hikma Pharmaceutical - Hikma launches Methotrexate Injection
03/05/2018 09:00Announcement
REG - Hikma Pharmaceutical - Total Voting Rights
01/05/2018 13:40Announcement
REG - Hikma Pharmaceutical - Holding(s) in Company
26/04/2018 13:45Announcement
REG - Hikma Pharmaceutical - Block listing Interim Review
25/04/2018 10:45Announcement
RCS - Hikma Pharmaceutical - Hikma expands licensing agreement with Rovi
24/04/2018 09:05Announcement